$1.70 -0.06 (-3.41%)
2/10/2012 4:00 PM

Allos Therapeutics, Inc. (NASDAQ:ALTH)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Featured Broker Partners


Advertisement